{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:21:26Z","timestamp":1767835286360,"version":"3.49.0"},"reference-count":54,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hong Kong Society of Gut Microbiome (HKSGM)"},{"name":"Hong Kong Psoriasis Patients Association"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Psoriasis is a chronic immune-mediated inflammatory disease affecting the skin and other systems. Gastrointestinal disease was found to be correlated with psoriasis in previous studies and it can significantly affect the quality of life of psoriasis patients. Despite the importance of the gut microbiome in gut and skin health having already been demonstrated in many research studies, the potential effect of probiotics on GI comorbidities in psoriasis patients is unclear. To investigate the effects of probiotics on functional GI comorbidities including irritable bowel syndrome, functional constipation, and functional diarrhea in psoriasis patients, we conducted a targeted 16S rRNA sequencing and comprehensive bioinformatic analysis among southern Chinese patients to compare the gut microbiome profiles of 45 psoriasis patients over an 8-week course of novel oral probiotics. All the participants were stratified into responders and non-responders according to their improvement in GI comorbidities, which were based on their Bristol Stool Form Scale (BSFS) scores after intervention. The Dermatological Life Quality Index (DLQI) score revealed a significant improvement in quality of life within the responder group (DLQI: mean 10.4 at week 0 vs. mean 15.9 at week 8, p = 0.0366). The proportion of psoriasis patients without GI comorbidity manifestation at week 8 was significantly higher than that at week 0 (week 0: Normal 53.33%, Constipation\/Diarrhea 46.67%; week 8: Normal 75.56%, Constipation\/Diarrhea 24.44%, p = 0.0467). In addition, a significant difference in the gut microbiome composition between the responders and non-responders was observed according to alpha and beta diversities. Differential abundance analysis revealed that the psoriasis patients exhibited (1) an elevated relative abundance of Lactobacillus acidophilus, Parabacteroides distasonis, and Ruminococcus bromii and (2) a reduced relative abundance of Oscillibacter, Bacteroides vulgatus, Escherichia sp., and Biophila wadsworthia after the 8-week intervention. The responders also exhibited a higher relative abundance of Fusicatenibacter saccharivorans when compared to the non-responders. In summary, our study discovers the potential clinical improvement effects of the novel probiotic formula in improving GI comorbidities and quality of life in psoriasis patients. We also revealed the different gut microbiome composition as well as the gut microbial signatures in the patients who responded to probiotics. These findings could provide insight into the use of probiotics in the management of psoriasis symptoms.<\/jats:p>","DOI":"10.3390\/microorganisms12010208","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T05:46:44Z","timestamp":1705643204000},"page":"208","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Novel Multi-Strain E3 Probiotic Formula Improved the Gastrointestinal Symptoms and Quality of Life in Chinese Psoriasis Patients"],"prefix":"10.3390","volume":"12","author":[{"given":"Pui Ling Kella","family":"Siu","sequence":"first","affiliation":[{"name":"Microbiome Research Centre, BioMed Laboratory Company Limited, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi Tung","family":"Choy","sequence":"additional","affiliation":[{"name":"Microbiome Research Centre, BioMed Laboratory Company Limited, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen Hoi Yin","family":"Chan","sequence":"additional","affiliation":[{"name":"Microbiome Research Centre, BioMed Laboratory Company Limited, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross Ka Kit","family":"Leung","sequence":"additional","affiliation":[{"name":"Microbiome Research Centre, BioMed Laboratory Company Limited, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Un Kei","family":"Chan","sequence":"additional","affiliation":[{"name":"Microbiome Research Centre, BioMed Laboratory Company Limited, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Microbiome Research Centre, BioMed Laboratory Company Limited, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi Ho","family":"Wong","sequence":"additional","affiliation":[{"name":"Microbiome Research Centre, BioMed Laboratory Company Limited, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuk Wai","family":"Lee","sequence":"additional","affiliation":[{"name":"Microbiome Research Centre, BioMed Laboratory Company Limited, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Wang","family":"Chan","sequence":"additional","affiliation":[{"name":"Microbiome Research Centre, BioMed Laboratory Company Limited, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia Jun Yi","family":"Lo","sequence":"additional","affiliation":[{"name":"Microbiome Research Centre, BioMed Laboratory Company Limited, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph Chi Ching","family":"Tsui","sequence":"additional","affiliation":[{"name":"Microbiome Research Centre, BioMed Laboratory Company Limited, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven King Fan","family":"Loo","sequence":"additional","affiliation":[{"name":"Microbiome Research Centre, BioMed Laboratory Company Limited, Hong Kong, China"},{"name":"Hong Kong Institute of Integrative Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China"},{"name":"Dermatology Centre, CUHK Medical Centre, The Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0686-4259","authenticated-orcid":false,"given":"Stephen Kwok Wing","family":"Tsui","sequence":"additional","affiliation":[{"name":"Microbiome Research Centre, BioMed Laboratory Company Limited, Hong Kong, China"},{"name":"School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China"},{"name":"Centre for Microbial Genomics and Proteomics, The Chinese University of Hong Kong, Hong Kong, China"},{"name":"Hong Kong Bioinformatics Centre, The Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,19]]},"reference":[{"key":"ref_1","unstructured":"Nair, P.A., and Badri, T. (2023). StatPearls, StatPearls Publishing LLC."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: A brief overview","volume":"21","author":"Raharja","year":"2021","journal-title":"Clin. Med."},{"key":"ref_3","unstructured":"(2023, November 15). News.Gov.Hk. Treatment for Psoriasis Patients, Available online: https:\/\/www.info.gov.hk\/gia\/general\/201511\/04\/P201511040716.htm."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/annrheumdis-2018-214065","article-title":"Prevalence and incidence of psoriasis and psoriatic arthritis","volume":"78","author":"Sewerin","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","article-title":"Signaling pathways and targeted therapies for psoriasis","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/bjd.18245","article-title":"Management of psoriasis as a systemic disease: What is the evidence?","volume":"182","author":"Korman","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/bjd.14528","article-title":"Association between psoriasis and inflammatory bowel disease: A Danish nationwide cohort study","volume":"175","author":"Egeberg","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jdv.12847","article-title":"Risk of non-alcoholic fatty liver disease in patients with psoriasis: A systematic review and meta-analysis","volume":"29","author":"Candia","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/1203475415586332","article-title":"The Relationship of Obesity With the Severity of Psoriasis: A Systematic Review","volume":"19","author":"Fleming","year":"2015","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: Epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00403-017-1775-7","article-title":"Digestive system in psoriasis: An update","volume":"309","author":"Pietrzak","year":"2017","journal-title":"Arch. Dermatol. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1007\/s00018-017-2509-x","article-title":"Mechanisms and consequences of intestinal dysbiosis","volume":"74","author":"Weiss","year":"2017","journal-title":"Cell Mol. Life Sci."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Thye, A.Y., Bah, Y.R., Law, J.W., Tan, L.T., He, Y.W., Wong, S.H., Thurairajasingam, S., Chan, K.G., Lee, L.H., and Letchumanan, V. (2022). Gut-Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis. Biomedicines, 10.","DOI":"10.3390\/biomedicines10051037"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/jdv.15951","article-title":"The gut microbiome alterations in allergic and inflammatory skin diseases\u2014An update","volume":"34","author":"Gerkowicz","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.3889\/oamjms.2019.827","article-title":"Gut Microbiota and the Alteration of Immune Balance in Skin Diseases: From Nutraceuticals to Fecal Transplantation","volume":"7","author":"Vojvodic","year":"2019","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2096995","DOI":"10.1080\/19490976.2022.2096995","article-title":"Impact of gut microbiome on skin health: Gut-skin axis observed through the lenses of therapeutics and skin diseases","volume":"14","author":"Mahmud","year":"2022","journal-title":"Gut Microbes"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaad.2018.06.056","article-title":"Psoriasis: Which therapy for which patient: Focus on special populations and chronic infections","volume":"80","author":"Kaushik","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Lee, H.J., and Kim, M. (2023). Challenges and Future Trends in the Treatment of Psoriasis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241713313"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics","volume":"80","author":"Menter","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jaad.2020.02.044","article-title":"Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies","volume":"82","author":"Menter","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/jdv.16684","article-title":"Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 1)","volume":"34","author":"Lambert","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaad.2019.04.042","article-title":"Joint American Academy of Dermatology\u2013National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy","volume":"81","author":"Elmets","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Polak, K., Bergler-Czop, B., Szczepanek, M., Wojciechowska, K., Fr\u0105tczak, A., and Kiss, N. (2021). Psoriasis and Gut Microbiome-Current State of Art. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094529"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/exd.13786","article-title":"Intestinal microbiota profiling and predicted metabolic dysregulation in psoriasis patients","volume":"27","author":"Chen","year":"2018","journal-title":"Exp. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/bjd.17931","article-title":"Gut microbiota dysbiosis in a cohort of patients with psoriasis","volume":"181","author":"Delgado","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Choy, C.T., Chan, U.K., Siu, P.L.K., Zhou, J., Wong, C.H., Lee, Y.W., Chan, H.W., Tsui, J.C.C., Loo, S.K.F., and Tsui, S.K.W. (2023). A Novel E3 Probiotics Formula Restored Gut Dysbiosis and Remodelled Gut Microbial Network and Microbiome Dysbiosis Index (MDI) in Southern Chinese Adult Psoriasis Patients. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076571"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/apt.13746","article-title":"Validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome","volume":"44","author":"Blake","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/jdv.12106","article-title":"Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The correlation between disease severity and psychological burden in patients treated with biological therapies","volume":"28","author":"Mattei","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_30","unstructured":"(2018). Clinical Review Report: Guselkumab (Tremfya): (Janssen Inc.): Indication: For the Treatment of Adult Patients with Moderate-to-Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy or Phototherapy, Canadian Agency for Drugs and Technologies in Health."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/ismej.2012.8","article-title":"Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms","volume":"6","author":"Caporaso","year":"2012","journal-title":"ISME J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-010-0166-z","article-title":"Health benefits of probiotics: Are mixtures more effective than single strains?","volume":"50","author":"Chapman","year":"2011","journal-title":"Eur. J. Nutr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.3748\/wjg.v21.i10.3072","article-title":"Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis","volume":"21","author":"Didari","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1038\/s41467-020-17041-7","article-title":"Analysis of compositions of microbiomes with bias correction","volume":"11","author":"Lin","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Buha\u0219, M.C., Gavrila\u0219, L.I., Candrea, R., C\u0103tinean, A., Mocan, A., Miere, D., and T\u0103taru, A. (2022). Gut Microbiota in Psoriasis. Nutrients, 14.","DOI":"10.3390\/nu14142970"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Mosca, A., Leclerc, M., and Hugot, J.P. (2016). Gut Microbiota Diversity and Human Diseases: Should We Reintroduce Key Predators in Our Ecosystem?. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.00455"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/nrmicro2690","article-title":"Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa","volume":"10","author":"Bron","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.3168\/jds.S0022-0302(89)79389-9","article-title":"Acidophilus milk products: A review of potential benefits to consumers","volume":"72","author":"Gilliland","year":"1989","journal-title":"J. Dairy. Sci."},{"key":"ref_40","first-page":"737","article-title":"Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori","volume":"80","author":"Wang","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.4014\/jmb.2205.05041","article-title":"The Functional Roles of Lactobacillus acidophilus in Different Physiological and Pathological Processes","volume":"32","author":"Gao","year":"2022","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.carbpol.2013.04.028","article-title":"Structure and anti-inflammatory capacity of peptidoglycan from Lactobacillus acidophilus in RAW-264.7 cells","volume":"96","author":"Wu","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2249.2010.04286.x","article-title":"Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition","volume":"163","author":"Kverka","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/1346-8138.14933","article-title":"Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls","volume":"46","author":"Shapiro","year":"2019","journal-title":"J. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Stehlikova, Z., Kostovcikova, K., Kverka, M., Rossmann, P., Dvorak, J., Novosadova, I., Kostovcik, M., Coufal, S., Srutkova, D., and Prochazkova, P. (2019). Crucial Role of Microbiota in Experimental Psoriasis Revealed by a Gnotobiotic Mouse Model. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.00236"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1099\/jmm.0.46198-0","article-title":"Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis","volume":"55","author":"Lucke","year":"2006","journal-title":"J. Med. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41564-021-01050-3","article-title":"Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity","volume":"7","author":"Mills","year":"2022","journal-title":"Nat. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1053\/j.gastro.2020.12.004","article-title":"Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis","volume":"160","author":"Galipeau","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13099-017-0208-7","article-title":"A human stool-derived Bilophila wadsworthia strain caused systemic inflammation in specific-pathogen-free mice","volume":"9","author":"Feng","year":"2017","journal-title":"Gut Pathog."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1574-6941.2009.00709.x","article-title":"Culture-independent analysis of desulfovibrios in the human distal colon of healthy, colorectal cancer and polypectomized individuals","volume":"69","author":"Scanlan","year":"2009","journal-title":"FEMS Microbiol. Ecol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1097\/MIB.0000000000000972","article-title":"A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients","volume":"22","author":"Takeshita","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e06432","DOI":"10.1016\/j.heliyon.2021.e06432","article-title":"Study of microbiome changes in patients with ulcerative colitis in the Central European part of Russia","volume":"7","author":"Gryaznova","year":"2021","journal-title":"Heliyon"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cgh.2018.09.028","article-title":"Prebiotics and Probiotics in Digestive Health","volume":"17","author":"Quigley","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_54","first-page":"207","article-title":"Therapeutic Effects of Prebiotics on Constipation: A Schematic Review","volume":"15","author":"Naseer","year":"2020","journal-title":"Curr. Clin. Pharmacol."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/1\/208\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:45:55Z","timestamp":1760103955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/1\/208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["microorganisms12010208"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms12010208","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,19]]}}}